AOD-9604
Human research — investigational use
Research-only / investigational — not FDA approved
Investigational; no FDA-approved drug label is established for this entry. Source: FDA: safety concerns for nominated peptide substances
What it is
A modified fragment of human growth hormone. Source: FDA review of AOD-9604-related substances
What it has been studied for
Obesity studies assessed by FDA did not establish effectiveness for weight reduction. Source: FDA review of AOD-9604-related substances
Mechanism
Developed to investigate fat metabolism; the proposed mechanism does not establish clinical benefit. Source: FDA review of AOD-9604-related substances
Documented dosing
No applicable general-use human dose range, frequency or cycle is documented here. Numbers from other routes, formulations or conditions are not interchangeable.
Pairings & cautions
No evidence-based peptide pairing is specified in this entry.
FDA identifies unresolved safety concerns for this substance. Source: FDA: safety concerns for nominated peptide substances
These are selected considerations, not a complete safety review. Discuss the full source and your medications with your prescriber.
Sources
- FDA review of AOD-9604-related substances · Clinical / regulatory reference
- FDA: safety concerns for nominated peptide substances · Clinical / regulatory reference